Supplement Facts
Call 877 240-7529 for case discounts - HUGE saving
Suggested Use:
As a dietary supplement take 2 tablets twice daily on an empty stomach or as directed by your health care professional.
Serrapeptase - 120 caps
Serrapeptase, also known as Serratio Peptidase, is a proteolytic enzyme that is produced commercially in the laboratory and it is isolated from the microorganism, Serratia E15. Originally it was found being used by silkworms to aid digestion and dissolve its chrysalis. Serratia E15 can be used effectively for inflammation in all forms. The uses are wide ranging and cover just about every condition that is affected by inflammation and/or non-living tissue and is being used extensively in Asia and Europe.
Serrrapeptase is a good alternative to salicylates (such as aspirin), ibuprofen, and other NSAIDS as well as steroids- providing relief for those suffering with a wide array of autoimmune diseases that affect the inflammatory response, including ulcerative colitis, psoriasis, uveitis, allergies, and some forms of cancer.
Although steroidal and non-steroidal anti-inflammatory drugs may offer temporary, symptomatic relief from pain, swelling and inflammation, they may also be immuno-suppressive. They are known to have dangerous side effects. Serrapeptase, on the other hand, eases pain and swelling with no inhibitory effects on prostaglandins and has no gastrointestinal side effects.
Serrapeptase as an anti-inflammatory in Europe and Asia has been in clinical use for over twenty five years. Treatment includes chronic sinusitis, elimination of broncho-pulmonary secretions (the enzyme breaks down protein fibers, allowing mucous to thin), sprains and torn ligaments, and other traumatic injuries, idiopathic edema, as well as post-operative inflammation.
The late German physician, Dr. Hans Nieper, used Serrapeptase to treat arterial blockage in his coronary patients, reporting that Serrapeptase also dissolves blood clots, and causes varicose veins to shrink or diminish..
Some Studies
Studying postoperative swelling and pain reduction of the upper ankle joint, a test was carried out in 3 randomized groups of 66 patients, each with fresh rupture of the lateral ligament treated surgically between December 1986 and April 1987. The group receiving Serrapeptase saw a 50% decrease in swelling on the third postoperative day. Decreased pain, for the most part, correlated with reduction in swelling. The Serrapeptase group became rapidly pain-free. The two control groups, using traditional elevation of the leg, bed rest, with and without applications of ice, had no reduction in swelling at that time. (Esch PM, Gerngross H, Fabian A, Fortachr Med,107(4):67.8, 71-2 1989 Feb 10)
Serrapeptase in a 70 patient, double-blind controlled trial treating breast engorgement saw Serrapeptase improve breast pain and swelling in significant numbers of the treatment group with no adverse reactions. (Kee WH, Tan SL; Lee V, Salmon YM .Singapore Med J, 30(I) :48-54 1989 Feb)
120 tablets, 5 mg
ENTERIC coated
Serrapeptase Facts
Nutrition System Benefits from Don Bodenbach
Don's Four Laws of Nutritional Supplements
The Road to Results
1-877-240-7528
sales@crohns.net&
Help
100% Secure
Basket
